Toggle Main Menu Toggle Search

Open Access padlockePrints

Olanzapine oro-dispersible (Velotab™) - An alternative to depot?

Lookup NU author(s): Denise Johnson


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


INTRODUCTION: Olanzapine oro-dispersible (Velotab™) was introduced to the United Kingdom in May 2000. It rapidly dissolves in the mouth, and therefore patients may find it preferable to swallowing tablets. Another advantage is that the opportunity to hide the medication is much reduced. The study examined the usage of Velotab™ in a forensic psychiatry setting. METHOD: Drug expenditure for different classes of antipsychotic was examined for 6 months before and 7 months after the introduction of olanzapine Velotab™. RESULTS: The results showed a change in prescribing practice, with a significant inverse correlation between the use of Velotab™ and depot medication. CONCLUSION: This suggests that forensic psychiatrists, who may have particular concerns about compliance, had confidence in oro-dispersible administration as an alternative to depot medication. It is suggested that making other neuroleptics available in an oro-dispersible form would allow for a wider choice of atypicals in populations in whom there are significant compliance problems.

Publication metadata

Author(s): Johnson D, Rai S, Milne S

Publication type: Article

Publication status: Published

Journal: International Journal of Psychiatry in Clinical Practice

Year: 2002

Volume: 6

Issue: 3

Pages: 163-165

ISSN (print): 1365-1501

ISSN (electronic): 1471-1788

Publisher: Informa Healthcare


DOI: 10.1080/136515002760276090


Altmetrics provided by Altmetric


Find at Newcastle University icon    Link to this publication